These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 744256

  • 1. [Metabolism of vincamine in the rat].
    Viganò V, Paracchini S, Piacenza G, Pesce E.
    Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of vincamine in the rat in vivo and in vitro.
    Vereczkey L, Tamás J, Czira G, Szporny L.
    Arzneimittelforschung; 1980 Aug; 30(11):1860-5. PubMed ID: 7192994
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Absorption, distribution and elimination of vincamine hydrochloride in the rat].
    Vigano V, Rognoni F, Piacenza G, Pesce E.
    Farmaco Prat; 1978 May; 33(5):224-31. PubMed ID: 744225
    [No Abstract] [Full Text] [Related]

  • 5. The metabolic fate of 11-bromo[15-3H]vincamine in man.
    Mayo BC, Biggs SR, Hawkins DR, Chasseaud LF, Darragh A, Leaf FC.
    Eur J Drug Metab Pharmacokinet; 1985 May; 10(3):189-96. PubMed ID: 4085521
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The metabolic fate of 11-bromo-[15-3H] vincamine in rats, dogs and humans.
    Mayo BC, Biggs SR, Hawkins DR, Chasseaud LF, Darragh A, Baldock GA, Whitby BR.
    J Pharmacobiodyn; 1982 Dec; 5(12):951-64. PubMed ID: 7169608
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
    Millart H, Lamiable D, Houin G, Plat M, Choisy H, Tillement JP.
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
    [Abstract] [Full Text] [Related]

  • 14. Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance.
    Dahms M, Lotz R, Lang W, Renner U, Bayer E, Spahn-Langguth H.
    Drug Metab Dispos; 1997 Apr; 25(4):442-52. PubMed ID: 9107544
    [Abstract] [Full Text] [Related]

  • 15. [Biologic availability of vincamine from tablets with a hydrophilic matrix. II].
    Rolland A, Gibassier D, Chemtob C, Le Verge R.
    J Pharm Belg; 1984 Apr; 39(3):136-44. PubMed ID: 6481608
    [No Abstract] [Full Text] [Related]

  • 16. [Kinetic behavior of 3H-vincamine in man. Compartmental analysis].
    Camón L, Rodríguez Farré E, Valdecasas FG.
    Arch Farmacol Toxicol; 1978 Apr; 4(1):39-40. PubMed ID: 697401
    [No Abstract] [Full Text] [Related]

  • 17. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W, Erlaçin S, Frankus E, Uragg H.
    Arzneimittelforschung; 1981 Apr; 31(11):1932-43. PubMed ID: 7198474
    [Abstract] [Full Text] [Related]

  • 18. Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
    Maincent P, Le Verge R, Sado P, Couvreur P, Devissaguet JP.
    J Pharm Sci; 1986 Oct; 75(10):955-8. PubMed ID: 3795026
    [Abstract] [Full Text] [Related]

  • 19. Kinetic metabolism of vinpocetine in the rat.
    Vereczkey L, Szentirmay Z, Szporny L.
    Arzneimittelforschung; 1979 Oct; 29(6):953-6. PubMed ID: 582790
    [Abstract] [Full Text] [Related]

  • 20. [Biopharmaceutics of vincamine salts after oral administration in humans].
    Aiache JM, Turlier M, Sibaud Y.
    Farmaco Prat; 1985 Mar; 40(3):87-100. PubMed ID: 3996561
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.